BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 908015)

  • 1. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL; Boyer CM; Purnell DM
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single versus double preoperative intralesional BCG in 13762 mammary adenocarcinoma.
    Lee YT
    J Surg Oncol; 1979; 12(3):243-52. PubMed ID: 502566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.
    Sparks FC; O'Connell TX; Lee YT
    Surg Forum; 1973; 24():118-21. PubMed ID: 4618633
    [No Abstract]   [Full Text] [Related]  

  • 7. Intralesional Bacillus Calmette-Guérin immunotherapy of canine venereal tumors.
    Hess AD; Catchatourian R; Zander AR; Epstein RB
    Cancer Res; 1977 Nov; 37(11):3990-4. PubMed ID: 143344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors.
    Lamm DL; Harris SC; Gittes RF
    Invest Urol; 1977 Mar; 14(5):369-72. PubMed ID: 844999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
    Bogden AE; Esber HJ; Taylor DJ; Gray JH
    Cancer Res; 1974 Jul; 34(7):1627-31. PubMed ID: 4857731
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
    Yron I; Cohen D; Robinson E; Haber M; Weiss DW
    Cancer Res; 1975 Jul; 35(7):1779-90. PubMed ID: 1093676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent adjuvant effects of Bacillus Calmette-Guérin on tumor immunity in Lewis rats.
    Davies M; Sabbadini E
    Cancer Res; 1979 Mar; 39(3):959-65. PubMed ID: 311684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of preoperative intralesional BCG and postoperative 5-FU chemotherapy in three adenocarcinoma lines in rats.
    Lee YT
    J Surg Oncol; 1979; 11(4):295-304. PubMed ID: 449359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
    Greager JA; Baldwin RW
    Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
    [No Abstract]   [Full Text] [Related]  

  • 17. The antimetastatic effect of IV-inoculated BCG on adenocarcinomas in the prostate-seminal vesicle complex of L-W rats.
    Pollard M; Luckert PH
    Anticancer Res; 1994; 14(3A):901-3. PubMed ID: 8074491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.
    Bogden AE; Esber HJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):97-100. PubMed ID: 748802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.